Background: Hyaluronan (HA) contributes to the extracellular matrix in bone marrow. Results: HA expressed by the hematopoietic microenvironment supports hematopoiesis and is involved in hematopoietic stem/progenitor cell migration by regulating the production of soluble factors. Conclusion: Endogenous HA is an important regulatory element of the hematopoietic microenvironment. Significance: Understanding the biology of HA may help to develop strategies for improving the quality of the stem cell microenvironment.
The bone marrow microenvironment regulates several functions of hematopoietic stem/progenitor cells (HSPC), 2 including their recruitment into the bone marrow following transplantation. One mechanism by which the microenvironment regulates HSPC homing is by influencing the production of chemokines that mediate HSPC migration. The chemokine SDF-1 and its cognate receptor CXCR4 are known to play an important role in mediating homing of both long-term reconstituting HSCs (1) and committed hematopoietic progenitor cells (2) , although a subset of HSCs has been identified that homes in a SDF-1/CXCR4-independent manner (3). Other chemokines, including CCL19 and CCL21, are predominantly chemotactic for committed hematopoietic progenitor cells (4) . In addition to chemokines, growth factors produced in the bone marrow contribute indirectly to the recruitment of HSPC by regulating the expression of CXCR4 on HSPCs (5), or by inducing the release of CCL12 and other chemokines from intracellular storage (6) .
Effective recruitment of circulating HSPCs into bone marrow depends on the balance of chemokines and growth factors present, which is itself influenced by a variety of factors including the bone marrow cellular composition, stress factors, inflammation, circadian rhythms, disease development, and therapeutic interventions (7) (8) (9) . Thus, the quality of the microenvironment has a profound impact on homing of HSPC to the bone marrow and the subsequent efficiency of stem cellbased tissue regeneration. This makes the bone marrow microenvironment an important therapeutic target, the health of which might be improved by a "pretransplant conditioning" prior to stem cell transfer to promote tissue regeneration.
Extracellular matrix (ECM) molecules produced by cells within the bone marrow contribute to the highly complex structure of the regulatory microenvironment (10, 11) . Although some ECM components, such as collagens, fibronectin, laminin, and hemonectin, are known to participate in the bone marrow regulatory network (10, 11) , the role of other ECM components, including hyaluronan (HA), remains unclear. HA is a member of the glycosaminoglycan polysaccharide family and is a major component of the bone marrow ECM (12) . HA is a negatively charged polymer consisting of repeating disaccharides of N-acetyl-D-glucosamine (GlcNAc) and glucuronic acid (GlcA) residues, and is involved in regulating many cellular functions, including proliferation (13, 14) , migration (15) , cytokine production (16, 17) , and expression of adhesion molecules (18) . The effects of HA on cell functions are mediated by the HA receptors including CD44, RHAMM, and HARE, all of which have been shown to induce intracellular signaling and regulate gene transcription (19) . Although the involvement of HA in normal cell and tumor cell biology is generally appreciated, there is a large gap in our understanding of how HA contributes to the regulation of the bone marrow microenvironment.
We have previously demonstrated that HA can directly stimulate cytokine production from bone marrow-resident cells, and thus is not a passive structural element of the bone marrow ECM, but a necessary and specific signal-inducing molecule for hematopoiesis (16) . In the present study we have extended these observations to show that HA stimulates cells of the hematopoietic microenvironment in an autocrine fashion to produce a range of soluble factors, including cytokines and chemokines that mediate the motility of hematopoietic cells. Moreover, we demonstrate that enforced reduction of bone marrow HA levels inhibits the ability of the microenvironment to support hematopoiesis and to recruit circulating HSPCs into bone marrow in vivo. Our findings support an important regulatory role for endogenous HA as an integral part of the hematopoietic microenvironment.
EXPERIMENTAL PROCEDURES
Mice-All animal experiments were conducted according to NIH guidelines and in agreement with the Torrey Pines Institute for Molecular Studies (TPIMS) policy and Sanford-Burnham Medical Research Institute (SBMRI) policy on animal use, and were approved by the Institutional Animal Care and Use Committees (IACUC). C57BL/6 and BALB/c mice were from the Jackson Laboratories. The generation of the loxP-modified Has2 flox allele and Prx1-Cre;Has2 flox/flox conditional knock-out mice has been reported previously (20) . Constitutive Has1 knock-out mice were created by replacing a part of exon 5 encoding the catalytic site of the enzyme (21) . Constitutive Has3 knock-out mice (22) were kindly provided by Dr. John
McDonald (University of Utah). Has1
Ϫ/Ϫ ;Has3 Ϫ/Ϫ double constitutive knock-out mice (dKO) and Prx1-Cre;Has2 flox/flox ; Has1 Ϫ/Ϫ ;Has3 Ϫ/Ϫ triple knock-out mice were bred from these lines in 100% C57BL/6 background. Levels of endogenous HA were reduced by irradiation (11 gray) of C57BL/6 mice (8-weekold females, 10 mice per group) followed by immediate intravenous injection of 100 l of 3 mM 4-methylumbelliferone (4MU, an HA synthesis inhibitor (23); Sigma). Animals received three additional intravenous injections of 100 l of 3 mM 4MU with 6-h intervals. Control mice were subjected to the same treatment except they received injections of an equal volume of vehicle (phosphate-buffered saline, PBS). To evaluate the efficiency of HSC homing, lineage-negative cells (LinϪ, 2 ϫ 10 6 cells/mouse) were purified from bone marrow of C57BL/6 mice (8-week-old females) using MACS (Miltenyi Biotec, Auburn, CA) and were injected intravenously into irradiated and PBSor 4MU-treated mice. Twenty-four hours later, mice were sacrificed, bone marrow was collected from femurs and tibias, and the number of HSCs recruited into the bone marrow was determined by competitive reconstitution assays (CRA).
Competitive Reconstitution Assay-C57BL/6JolaHsd Pep3 a (CD45.2) and C57Bl/6.SJL.Ptprc a Pep3 b /BoyJ (CD45.1) mice (referred to here as B6/CD45.2 and B6/CD45.1 mice, respectively, Jackson Laboratories) were used for this assay. B6/CD45.2 mice were used as "donors," and sex-and age-matched B6/CD45.1 mice were used as "competitors." Two-month-old recipient B6/ CD45.1 mice were lethally irradiated (11 gray), then reconstituted with bone marrow cells purified from B6/CD45.2 donors (2 ϫ 10 5 /mouse) and B6/CD45.1 competitors (10 6 /mouse). Eight weeks after cell transplantation, peripheral blood was harvested from the recipient mice, and mature mononuclear cells derived from donor or competitor HSCs were detected by FACS analysis using antibodies specific for CD45.1 (clone A20, eBioscience, San Diego, CA) or CD45.2 (clone 104, Invitrogen). The percentage of donor-derived CD45.2-positive cells generated in the recipients was then calculated.
Cell Culture and Reagents-Mouse stromal fibroblast-like cell lines M10B4 and MS-5 were cultured in DMEM supplemented with 10% FCS, and the S-17 cell line was cultured in RPMI (Invitrogen) with 5% FCS. The mouse progenitor cell line FDCP-mix was cultured in Iscove's medium supplemented with 20% horse serum (StemCells Technologies, Vancouver, Canada) and 10% WEHI-3B-conditioned medium. The mouse bone marrow-derived endothelial cell line STR-12 and lung microvasculature-derived LEISVO endothelial cell line are a gift from Dr. Kobayashi, Hokkaido University, School of Medicine, Sapporo, Japan, and were cultured in RPMI supplemented with 10% FCS (24) . Human mesenchymal stem cells (MSC) were cultured in ␣-minimal essential medium (Invitrogen) supplemented with 16.5% FCS and 2 mM L-glutamine (Sigma). Mouse MSCs were cultured in RPMI supplemented with 10% FBS, 50 g/ml of penicillin, and 50 g/ml of streptomycin.
Long Term Bone Marrow Culture (LTBMC) and CFU Assays-LTBMC were established according to standard protocols using bone marrow from C57BL/6 or BALB/c mice. Briefly, bone marrow cells (10 6 cells/ml) were cultured for 8 weeks in ␣-minimal essential medium supplemented with horse serum, fetal bovine serum, i-inositol, folic acid, 2-mercaptoethanol, L-glutamine, and 10 Ϫ6 M hydrocortisone (MyeloCult, StemCell Technologies) in 6-well tissue culture plates (VWR, Brisbane, CA) at 37°C in a humidified atmosphere containing 5% CO 2 . During each weekly feeding, nonadherent cells were collected from the culture medium, counted, and used in CFU assays. For the CFU assay, 10 4 cells/ml of nonadherent cells were cultured in methylcellulose media supplemented with cytokines (MethoCult, StemCell Technologies). Colonies were counted under an inverted microscope after 7 and 14 days of culture. Where indicated, bone marrow cells were collected from control wild type (WT) mice, dKO (Has1 ). Endogenous synthesis of HA in LTBMC was inhibited by the addition of 300 M 4MU, which was added at day 1, then every week thereafter. Where indicated, the cultures were treated with 100 g/ml of endotoxinfree HA (600 -1,500 kDa, purified from umbilical cord (Ͻ5% protein and chondroitin sulfate (CS) total impurities, Sigma), recombinant HA (200 and 15 kDa, Lifecore Biomedical, Chaska, MN), 10 units of bovine hyaluronidase (testicular hydrolase, Sigma), 100 g/ml of CS (Sigma) or CD44 specific antibody (clone KM201, Abcam). To prepare conditioned media (CM), the adherent layers of LTBMC were cultured in serum-free DMEM supplemented with 4.5 g/liter of glucose and sodium pyruvate for 12 h, followed by stimulation with 100 g/ml of HA. CM was collected 24 h later and used for cytokine and chemokine, ELISA, and Transwell assays.
Time Lapse Video Recording-Microscopy and video recording of the adherent cell layer of LTBMC was performed on a Leica DM IRBE microscope using a ϫ20 objective. Images were obtained with a Hamamatsu digital camera (Hamamatsu Photonics, Hamamatsu City, Japan) and analyzed with Improvision OpenLab 3.0 software (Improvision, Boston, MA), which allows the determination of motility of individual cells. Distance and time of travel of 10 individual cells from each culture was tracked, calculated, and normalized to mm/s.
Flow Cytometry-Detection of CD45.1 and CD45.2 on murine peripheral blood mononuclear cells was determined with a standard FACS protocol using anti-mouse CD45.1-FITC (clone A20, eBioscience, San Diego, CA) and anti-mouse CD45.2-phycoerythrin (clone 104, Invitrogen) antibodies. Phycoerythrin-and FITC-conjugated isotype control antibodies were from BD Pharmingen and Invitrogen, respectively. The presence of HA on the STR-12 cell surface was detected by incubating cells with 2 g/ml of biotinylated HA-binding protein (bHABP, Sigma) for 2 h. Staining was visualized by incubating the STR-12 cells with 10 g/ml of Alexa Fluor 546-conjugated streptavidin (Invitrogen) for 15 min. As a negative control, the STR-12 cells were pretreated with 200 units/ml of hyaluronidase for 2 h prior to staining with bHABP. Fluorescence intensity was analyzed on a FACScalibur (Becton Dickinson, San Jose, CA) according to standard procedures.
In Vitro Microcapillary Flow Assay-Rolling and adhesion of hematopoietic cells under physiological shear stress was assessed in vitro using microcapillary tubes coated with a monolayer of STR-12 endothelial cells. Briefly, glass capillaries (Fisher Scientific, Pittsburgh, PA) were coated with 2% 3-aminopropyltriethoxysilane in acetone (Sigma), washed twice with PBS, dried, and sterilized. Thereafter, the capillaries were coated with 5 mg/ml of gelatin type B (Sigma) for 30 min at 37°C. STR-12 endothelial cells were grown in the glass capillaries until 100% confluent. Where indicated, STR-12 cells were grown in the presence of 300 M 4MU. Defined levels of flow (wall shear stress) were applied to the capillaries by perfusing warm media (RPMI containing 0.75 mM Ca 2ϩ and Mg 2ϩ and 0.2% HSA) through a constant infusion syringe pump (Harvard Apparatus, Holliston, MA). The capillaries were then perfused with 10 ml of FDCP-mix (1 ϫ 10 5 cells/ml) at various levels of shear stress. At least five STR-12-coated capillaries were run in each experimental group. The interactions of the injected FDCP-mix cells with the endothelial layer were observed in the central sector of each capillary using an inverted phase-contrast microscope, and the images were recorded. Rolling FDCP-mix cells demonstrated multiple discrete interruptions and flowed slowly, whereas adherent cells remained stationary at a given point for extended periods of time (Ͼ30 s). All results are expressed as the number of rolling or adherent cells/field, representing the mean Ϯ S.D. from 5 capillaries.
Cytokine, Chemokine, and Growth Factor Assays-The production of a panel of cytokines, chemokines, and growth factors in murine BM cultures was quantified using the RayBio Mouse Cytokine Antibody Array III&3.1 and Quansys Biosciences platform, according to the manufacturer's recommendations.
Confocal Microscopy-STR-12 cells were cultured on poly-Dlysine-coated glass coverslips until 50% confluent. The cells were fixed with 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in PBS (Invitrogen) for 30 min. After washing and blocking with 2% FCS for 2 h at room temperature, the cells were treated with bHABP (Sigma) for 2 h at 4°C. After washing, the cells were incubated with FITC-conjugated avidin (BD Pharmingen) in PBS containing 2% FCS for 1 h at room temperature. Negative controls were treated identically except bHABP was omitted. After washing and staining the nuclei with DAPI (4Ј-6-diamidino-2-phenylindole) (Sigma) for 10 min, the cells were washed and covered with a drop of AntiFade (Molecular Probes, Invitrogen). Images were taken on an Olympus Fluoview FV1000 confocal microscope.
Transwell Chemotaxis Assay-A single cell suspension of bone marrow was loaded into the upper wells of Matrigelcoated Transwells (Corning, NY, 5-m pore size, 10 6 cells/insert). The lower wells contained media alone, or media supplemented with 50 ng/ml of SDF-1, control CM, or CM from HA-stimulated LTBMC. The assembled wells were incubated for 4 h in a 37°C incubator, then the upper compartments were removed, and the cells present in the lower compartments were collected, enumerated, and subjected to CFU assays.
Immunoblotting-Cell monolayers were lysed with modified RIPA buffer (50 mM Tris-HCl, pH 7.4, 10% glycerol, 1% Nonidet P-40, 150 mM NaCl, 5 mM MgCl 2 , 2 mM EDTA, 0.2 mM PMSF, 2 g/ml of leupeptin, 2 g/ml of aprotinin, 2 mM sodium pyrophosphate, 2 mM sodium vanadate, and 10 mM sodium fluoride) and clarified by centrifugation. The cell lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked with 4% dry milk in TBS-Tween and exposed to goat polyclonal HAS-1, HAS-2, or HAS-3 specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). Anti-body binding was detected using horseradish peroxidase (HRP)-conjugated donkey anti-goat secondary antibody (Santa Cruz Biotechnology) and revealed by enhanced chemiluminescence (ECL Plus, Amersham Biosciences Bioscience/GE Healthcare, Piscataway, NJ).
Detection of HA Concentrations-CM and cell lysate samples collected from LTBMC and STR-12 cultures were tested for HA concentrations by an ELISA-like assay (Echelon, Salt Lake City, UT) according to the manufacturer's instructions.
Statistical Analysis-Statistical analyses were carried out using Student's t test. ). We found that bone marrow cells isolated from control and dHAS1/3 KO mice were able to form an adherent layer that supported formation of "cobblestone" areas and generation of hematopoietic cells (Fig. 1A) . In contrast, bone marrow cells isolated from triple tHAS1/2/3 KO mice formed adherent layers that failed to support formation of hematopoietic foci (Fig. 1A) . Production of hematopoietic cells (Fig. 1B ) and hematopoietic progenitors (Fig. 1C) in LTBMC was compared between the groups. Although generation of hematopoietic cells and their progenitors in dHAS1/3 KO cultures was not different from those in control cultures, little hematopoietic activity was detected in tHAS1/2/3 KO cultures.
RESULTS

HAS Activity in Bone Marrow Cells of Mesenchymal Origin Is Required for Hematopoiesis in Vitro-
The expression of HAS1, HAS2, and HAS3 in bone marrowderived cells and in the adherent layer of LTBMC was examined by Western blot using HAS-specific antibodies ( Fig. 2A) . We found that HAS2 is expressed in bone marrow-derived endothelial cells, MSC, and its derivatives stromal fibroblast-like cells (S17, M10B4, and MS5) to various degrees. In addition, HAS2 was detected in the adherent layer of LTBMC (Fig. 2B) . In contrast, levels of HAS1 and HAS3 (not shown) were similar in all tested cells.
HAS expression correlated with HA production in LTBMC that had been cultured in specialized LTBMC media (MyeloCult) that supports hematopoietic activity in vitro (Fig. 2C) . Interestingly, the production of HA in LTBMC was significantly decreased when instead of hematopoiesis-supportive MyeloCult media cultures were grown in DMEM, which does not support hematopoiesis in vitro. To further investigate whether the production of endogenous HA is required for hematopoiesis, LTBMC cultured in MyeloCult media were treated with 4MU, an inhibitor of HA synthesis (23) (Fig. 2D) .
4MU Inhibits Hematopoiesis in LTBMC-4MU reduces the UDP-uronic acid availability in cells, and subsequently decreases synthesis of HA (25, 26) . Because 4MU was reported as toxic to cells at a concentration of 1 mM (27), we first tested the effect of different concentrations of 4MU on survival of nonadherent and adherent cells in LTBMC. The addition of 4MU to established steady state LTBMC for 24 h demonstrated a significant increase (p Ͻ 0.05) in the number of dead cells, as measured by trypan blue exclusion, which was detected at 700 M 4MU and higher concentrations, whereas no effect was detected at 100 and 300 M 4MU (supplemental Fig. S1A ). Similar results were obtained when the number of apoptotic cells was evaluated by measuring annexin V binding to the cell surface using FACS (supplemental Fig. S1B ). Interestingly, exposure of established steady state LTBMC to 4MU for 7 days (one feeding period of LTBMC) had no or only a mild effect on survival of cells at low (100 and 300 M) and intermediate (500 M and 700 M) concentrations, but dramatically (9 -10-fold, p Ͻ 0.05) increased the percentage of dead cells at 1 mM 4MU (supplemental Fig. S1, A and B) . However, exposure of the established steady state LTBMC to all tested concentrations of 4MU for 7 days resulted in a significant (p Ͻ 0.05) decrease in the number of hematopoietic cells and progenitors generated in treated cultures as compared with nontreated control (supplemental Fig. S2, A and B) , suggesting that the process of hematopoiesis is affected by 4MU. In contrast, the addition of 4MU directly to the CFU assays did not influence colony formation at concentrations of 100 and 300 M, whereas at concentrations of 500, 700, and 1000 M, both the number and size of colonies were significantly (p Ͻ 0.05) decreased (supplemental Fig. S2C ). Together, these findings suggest that 300 M is the highest nontoxic concentration of 4MU that can be used to study the effect of pharmacological inhibition of the HA synthesis on hematopoiesis in LTBMC.
Treatment of LTBMC with 300 M 4MU did not change the expression of HAS1 (not shown), whereas the expression of HAS2 and HAS3 proteins was decreased in the adherent layer of LTBMC (Fig. 2B) , which correlated with a 20-fold decrease in levels of HA secreted into the culture supernatant (Fig. 2D ). This magnitude of reduction had a striking physiological effect on LTBMC, as the addition of 300 M 4MU on the day of initiation of cultures completely abrogated hematopoiesis as measured by the number of nonadherent cells produced in 4MU-treated LTBMC compared with control during the whole period of culture (Fig. 3A) . To examine the influence of 4MU on the number of committed progenitors generated in culture during treatment, nonadherent cells were harvested from control and 4MU-treated LTBMC at each weekly feeding, washed, and cultured in methylcellulose in the presence of hematopoietic growth factors. Committed progenitor cells were detectable in the 4MU-treated cultures during the first week of culture, but there was a sharp decrease in the number of colony forming cells (CFC) over the subsequent weeks. As expected, the number of CFC present in control, untreated LTBMC increased steadily over the first 5 weeks of culture, forming a plateau during weeks 5 and 6 (Fig. 3B) .
Consistent with the negative effect of 4MU treatment on HA production and generation of CFC in LTBMC, reconstituting HA levels by addition of exogenous high molecular weight (HMW) (Ն1,500 kDa) HA to LTBMC significantly improved hematopoiesis, as demonstrated by the increased number of both nonadherent mature cells (Fig. 3C ) and their committed progenitors (Fig. 3D ) measured at week 3 of culture. Interestingly, the addition of CS to the 4MU-treated LTBMC also improved hematopoietic activity in these cultures by increasing the levels of nonadherent cells to those observed in controls (Fig. 3, C and D) , although to a lesser degree than seen with HA. As expected, the effect of exogenous HA in 4MU-treated LTBMC was blocked by the CD44-specific HA-binding block- ing antibody, which is in accordance with previously reported findings (16, 28 -30 ) (supplemental Fig. S2 ).
We next examined LTBMC microscopically to directly visualize the effect of 4MU-induced inhibition of endogenous HA synthesis on hematopoiesis. Examination of the control LTBMC revealed the formation of foci of hematopoiesis, the so called "cobblestone areas," within the adherent layer of control untreated LTBMC (Fig. 3E) . By contrast, this process was not efficient in the 4MU-treated cultures, where the adherent layer was formed but no discrete foci could be seen (Fig. 3F) .
HA-induced Factors Stimulate Cell Motility in Vitro-Next, time lapse photography of the adherent layers was performed to determine whether HA deprivation affected the motility of hematopoietic cells in LTBMC. Because 4MU prevents only de novo synthesis of HA, but does not degrade existing HA, the level of HA in the established steady state cultures was reduced using hyaluronidase. The results showed that both the speed of movement and the distance traveled by hematopoietic cells within the adherent layers was significantly decreased under conditions of HA deprivation. The effect of hyaluronidase was specific, as the addition of exogenous HA back to the cultures significantly increased hematopoietic cell movement. In line with this observation, the addition of HA into the control cultures increased cell motility (Fig. 4A) .
The stimulating effect of HA on the motility of hematopoietic cells in LTBMC could result directly from HA-stimulated intracellular signaling for motility (31) , or could arise secondarily to HA-stimulated production of soluble chemotactic factors. To test these possibilities, we first examined the effect of HA on the SDF-1-mediated chemotaxis of hematopoietic cells using Transwell assays in which HA was added into the lower wells. The results demonstrated that, in the absence of SDF-1, HA did not stimulate chemotaxis of either mature hematopoietic cells or progenitors (supplemental Fig. S4 ). These findings suggested that the HA-induced increase in motility of hematopoietic cells in LTBMC is likely not a direct effect of HA on hematopoietic cells, but rather results from HA-stimulated production of soluble chemotactic factors by the accessory microenvironmental cells.
To determine whether hematopoietic progenitors respond to the HA-induced chemokines, we used static Transwell assays to examine the effect of CM from HA-treated adherent LTBMC layers on SDF-1-mediated chemotaxis. We found that in contrast to HA alone (supplemental Fig. S4 ), the presence of HA-CM, but not CM from control untreated cultures (CCM), significantly increased the number of progenitors that migrated toward SDF-1 (Fig. 4B) . The low level of progenitor cell migration toward HA CM was also detected without SDF-1 (1.6 Ϯ 0.2 colony forming cells per well), whereas plain media and CCM had no effect (supplemental Fig. S5 ). Treatment of CCM or HA-CM with hyaluronidase did not influence the chemotactic ability of hematopoietic progenitors toward SDF-1 supplemented with CM. Similarly, the addition of exogenous HA into the CCM and HA-CM did not influence the chemotactic ability of hematopoietic cells toward SDF-1 (Fig. 4B) . These findings suggest that SDF-1-mediated chemotaxis of hematopoietic progenitors can be enhanced by soluble factors induced by HA in accessory bone marrow cells.
HA Stimulates Production of Soluble Factors by the Adherent Layer of LTBMC-To screen for HA-induced factors, we used protein microarray technologies to measure 62 distinct growth factors in individual LTBMC samples (Quansys Biosciences, UT, and RayBiotech, Inc., CA). Established adherent layers from steady state LTBMC were precultured for 12 h in serumfree medium, and then stimulated with serum-free medium supplemented with 100 g/ml of HMW HA (umbilical cord, 1,500 -600 kDa) or LMW HA (15 kDa). Control cultures received only serum-free media. After 24 h of stimulation, CM was harvested and analyzed for the presence of cytokines using two protein microarray platforms (from RayBiotech and Quansys Biosciences). As a negative control, plain culture medium not exposed to cells and supplemented with HMW HA or LMW HA was used. The results of both the RayBiotech platform (Fig. 4C) and Quansys Biosciences (Table 1) assays were consistent, and confirmed our previous findings that HA upregulates IL-1 and IL-6 in vitro (16) and in vivo (32) . The anal-FIGURE 4. Effect of HA on the production of chemotactic factors and cell motility in vitro. A, steady state LTBMC (4 weeks) were untreated (control, PBS) or treated with hyaluronidase (10 units/ml) or HMW HA (100 g/ml, umbilical cord, 600 -1,500 kDa) alone. Where indicated, hyaluronidase was washed away and HMW HA was added. After 72 h the velocity of 10 representative motile cells in control and treated LTBMC was calculated in time lapse videos and expressed as mean Ϯ S.D. The results of one of two similar experiments are shown. B, the effect of HMW HA CM from LTBMC on SDF-1-mediated chemotaxis of hematopoietic cells was tested using Matrigel-coated Transwells. Bone marrow cells that migrated toward plain media (C: control), control CM, or HMW HA CM supplemented with SDF-1 (50 ng/ml), were tested in triplicate. Where indicated, HMW HA (100 g/ml) or hyaluronidase (10 units/ml) was added to the CM. Migrated bone marrow cells were collected from the lower wells and further assayed for the number of migrated progenitors using methylcellulose cultures. Asterisk (*) indicates a statistically significant difference (p Ͻ 0.05) between Transwells containing SDF-1 alone versus Transwells containing SDF-1 plus HMW HA CM. C, LTBMC were established in 6-well plates and cultured for 3 weeks. Cells were starved for 12 h then stimulated with 100 g/ml of HMW or LMW HA diluted in serum-free media. Control cultures were incubated with serum-free media alone. After 24 h of incubation, supernatants were collected and analyzed for the presence of 62 different cytokines and chemokines using the RayBio Mouse Cytokine Antibody Array III and 3.1. The effect of HMW and LMW HA on the production of chemokines and cytokines compared with control, nonstimulated LTBMC is shown. The manufacturer's positive (P.C.) and negative (N.C.) controls for the assay are indicated, and the results of one test of two similar experiments are shown.
TABLE 1 The effect of HMW HA on cytokine and chemokine production in LTBMC
The control and HA CM samples were analyzed at dilutions of 1:5 and 1:25 using Quansys Q-Plex Mouse Cytokine Array. Quantification of images was performed using the Quansys Array software. The experiment has been performed twice with similar results.
Cytokines
Control CM HA CM yses of HA-CM from LTBMC extend these results to show that HMW HA also increased production of several chemokines, including MIP-1␣, MCP-1, CXCL16, SDF-1, and RANTES (Fig.  4C , Table 1 ). In addition, HMW HA stimulated the production of growth factors including G-CSF, IGFBP-3, IL-12, LIX, IL-9, KC, and soluble VCAM-1 (Fig. 4C , Table 1 ). Control culture medium with or without HA that were not exposed to cells showed negative results (not shown), indicating that the tested HA samples were not contaminated with detectable levels of soluble factors tested by the protein microarray.
In Vivo Model of Pharmacologically Induced HA DepletionHaving shown that HA-stimulated factors augmented migration of HSPC in vitro, we next determined if endogenous HA is important for HSPC motility and homing in vivo. Because constitutive knock-out of HAS2 results in embryonic lethality of mice (33), we tested an alternate in vivo model in which HA synthesis is transiently inhibited and the levels of HA in bone marrow are reduced. To ensure that the bone marrow is as completely depleted as possible, we combined two approaches: 1) lethal irradiation of mice to ablate hematopoietic tissue and to degrade endogenous HA produced by host bone marrow cells, and 2) pharmacological inhibition of HA synthesis to transiently prevent de novo production of HA by host bone marrow cells. A schematic of the experimental protocol for the in vivo experiments is shown in Fig. 5A .
We first assessed the ability of lethal irradiation and 4MU treatment to deplete endogenous HA. To do this, mice were lethally irradiated with 11 gray followed by four consecutive injections with 4MU (referred as "treated" in Fig. 5B ) or PBS (referred as "control") with 6-h intervals. Both control and treated mice were sacrificed after the fourth injection of 4MU or PBS, and bone marrow cells and peripheral blood cells were collected. The cells were lysed, and lysates were tested for the presence of HA by an ELISA-like assay. As shown in Fig. 5B , this treatment protocol was very effective in reducing endogenous HA levels, with a 20.5-fold reduction of HA in serum, a 20-fold decrease in bone marrow cells, and a 14-fold decrease in peripheral blood cells in treated mice, compared with HA levels in control mice. Thus, this approach is effective in markedly reducing HA expression in vivo, and the mice can be used as an experimental model in which HA levels in bone marrow are transiently decreased. ) . B, after the fourth 4MU or PBS injection, control and treated mice (n ϭ 3/group) were sacrificed and HA levels in serum, bone marrow cells (BMC) and peripheral blood cells (PBC) collected from each mouse were measured using an ELISA-like assay. C, after the fourth 4MU or PBS injection, control and treated mice (n ϭ 10/group, CD45.2 mice) received intravenous injection of lineagenegative (LinϪ) bone marrow cells enriched with HSCs as illustrated in supplemental Fig. S4 . After 24 h following cell administration the control and treated mice were sacrificed (donor mice), bone marrow cells were isolated, and the number of HSC that had homed into the recipients' bone marrow was tested using CRA as illustrated in supplemental Fig. S5 . The percent ratio between donor (CD45.2) and competitor (CD45.1) peripheral blood cells in recipients is shown. D, the survival of the CRA recipients (n ϭ 10/group, illustrated in supplemental Fig. S7 ) that received competitor bone marrow cells mixed with donor bone marrow cells from either control mice (PBS) or treated mice (4MU) is shown. This experiment was repeated twice.
Transient Depletion of Endogenous HA Reduces Homing of
Transplanted HSPC into Murine Bone Marrow-To test the effect of HA reduction on recruitment of transplanted HSPC into mouse bone marrow, we used a combination of two assays: 1) a standard homing assay to assess the ability of intravenously injected cells that circulate in blood to enter bone marrow, followed by 2) a classical CRA to evaluate the number of long-term reconstituting HSCs that entered the ablated bone marrow. Bl6/CD45.2 mice (C57BL/6JolaHsd Pep3 a ) were the source of donor cells, and Bl6/CD45.1 (C57Bl/6.SJL.Ptprc a Pep3 b /BoyJ) mice were both the source of competitor cells and the recipient mice for the reconstitution assays.
To test the role of HA associated with the microenvironment in HSC homing, we used a model of transient inhibition of HA in bone marrow (Fig. 5A) . HSPC isolated from healthy Bl6/ CD45.2 donors (step number 1) were injected into lethally irradiated Bl6/CD45.2 recipients pre-treated with 4MU or PBS (step number 2). In this setting, lethal irradiation not only degrades endogenous HA, but also eliminates endogenous HSC in the recipients resulting in hematopoietic ablation. This allows detecting donor HSCs injected after irradiation, which migrate into "empty" bone marrow. Twenty-four hours later, all Bl6/CD45.2 recipients were sacrificed, bone marrow cells were collected and used to further evaluate the number of the long term reconstituting HSC (Bl6/CD45.2) of the donor that had entered the bone marrow of the recipient (supplemental Fig. S6) .
To evaluate the number of HSCs in collected bone marrow samples, CRA was used (supplemental Fig. S7 ) (34) . Competitor bone marrow was isolated from healthy nontreated Bl6/CD45.1 mice. Thereafter, competitor Bl6/CD45.1 bone marrow cells and donor #2 Bl6/CD45.2 bone marrow cells were mixed and injected into lethally irradiated recipient Bl6/CD45.1 mice (recipient #2), after which the mice were allowed to recover for 8 weeks. The 8-week period allows HSC from the Bl6/CD45.2 donor #2 bone marrow cell suspension to engraft in Bl6/CD45.1 recipient #2 bone marrow and generate mature hematopoietic cells that can be detected by FACS as CD45.1 ϩ or CD45.2 ϩ cells (34). Recipient #2 mice were then sacrificed after 8 weeks and peripheral blood samples were analyzed for the presence of CD45.1 ϩ and CD45.2 ϩ leukocytes by FACS analysis (supplemental Fig. S5 ). We found that the number of CD45.2 ϩ cells in recipients #2 receiving bone marrow cells from HA-depleted 4MU-treated donor #2 mice was significantly lower than in recipients #2 receiving bone marrow from control donor #2 mice (Fig. 5C ). In addition, recipient #2 mice that received bone marrow from 4MU-treated donor #2 mice had reduced survival as compared with recipient #2 mice reconstituted with bone marrow from control donor #2 mice (Fig. 5D) . Together, these results suggest that a lower number of HSCs was recruited into bone marrow of the HA-depleted mice (lethally irradiated 4MU-treated recipients #1) as compared with controls (lethally irradiated PBS-treated recipients #1).
4MU Treatment of Endothelial Cells Decreases Adhesive Interactions between Hematopoietic Progenitors and Endothelial Cells under Conditions of Shear
Stress-In vivo, the process of homing includes rolling and adhesion of circulating cells to the luminal surface of endothelial cells, which is followed by chemokine-mediated transmigration. Therefore, we next investigated whether exposure to 4MU influences the level of the cell surface-associated HA in bone marrow-derived endothelial cells. We found that incubation of the bone marrowderived endothelial cell line STR-12 with 4MU significantly decreased the amount of HA on the cell surface, as examined by binding of HABP (Fig. 6A) . To quantitatively measure the levels of HA in STR-12, cells were cultured in the presence of 300 M 4MU. In control cultures 4MU was omitted. FACS analysis demonstrated that 55% of cells stopped production of HA (Fig.  6B) . Because autofluorescence of cells may change following treatment with 4MU and interfere with quantitative measurements of HA levels, we also used an ELISA-like assay. When STR-12 cells reached confluence, supernatant from control and 4MU-treated cultures was collected, cells were lysed, and the levels of HA in the collected samples were evaluated by the ELISA-like assay. We found that 4MU treatment significantly decreased both secreted HA and cell-associated HA in STR-12 cells (Fig. 6C) . Western blot analysis demonstrated that decreased levels of HA in 4MU-treated STR-12 cells is associated with decreased expression of HAS2 and HAS3 (Fig. 6D) .
Numerous reports have shown that rolling and adhesion of various cell types on endothelial cells under physiological flow involves interactions of CD44 with HA expressed on the microvasculature (35) (36) (37) . Because CD44 has been previously reported to mediate homing of HSPC (28), we next investigated whether the reduced expression of HA on bone marrow endothelial cells influenced rolling and adhesion of HSPC under shear stress conditions. The STR-12 bone marrow-derived endothelial cell line was cultured in glass microcapillaries and treated with 4MU to reduce cell surface-associated HA. Due to the large number of cells required for this assay, we used FDCPmix cells as a source of hematopoietic progenitors instead of primary HSCs. FDCP-mix cells showed reductions in both rolling and adhesion in microcapillaries lined with 4MU-treated endothelial cells, compared with control, untreated endothelial cells (Fig. 6E) . This result suggests that HA on the endothelial cell surface is involved in the initial steps of the HSC homing cascade, i.e. for rolling and subsequent adhesion. Although important, this finding indicates that the in vivo 4MU experiments cannot differentiate between effects of HA depletion in the hematopoietic microenvironment and effects of HA reduction on the luminal surface of vasculature that may cause decreased HSC homing and engraftment.
Abnormal Distribution of Hematopoietic Progenitors in tHAS1/2/3 KO Mice-Because HAS2 in tHAS1/2/3 KO mice is conditionally knocked out in cells of mesenchymal origin, and because these cells contribute to the structure of the hematopoietic microenvironment (38, 39) , the tHAS1/2/3 KO animal model might be a better tool to study the role of HA in regulation of the hematopoietic microenvironment specifically. Malfunctioning of the hematopoietic microenvironment might be reflected by abnormal distribution of hematopoietic progenitors within the hematopoietic tissues. Therefore, the CFU assay was used to test the number of hematopoietic progenitors in bone marrow, peripheral blood, spleen, and liver isolated from tHAS1/2/3 KO, dHAS1/3 KO, and WT mice. A decreased number of progenitors in bone marrow and an increased num-ber of granulocyte-macrophage progenitors in extramedullary sites such as peripheral blood, spleen, and liver were found in tHAS1/2/3 KO mice, as compared with WT and dHAS1/3 KO (Fig. 7) . Similarly, an abnormal distribution of erythroid and multipotent hematopoietic progenitors in tHAS1/2/3 KO mice as compared with dHAS1/3 KO mice and WT control was demonstrated, which confirms an important role for HA associated with the microenvironment in regulating hematopoietic homeostasis.
DISCUSSION
Although the quantity and quality of transplanted HSC are important for the recovery of hematopoiesis, the functional status of the regulatory hematopoietic microenvironment is a critical parameter that determines the regenerative function of HSCs. The ability of the regulatory microenvironment to support hematopoiesis, i.e. its quality, may be compromised under pathological circumstances such as during disease development or as a result of therapeutic interventions. Thus, the hematopoietic microenvironment is a potentially important therapeutic target and should be allowed to recover prior to HSC transplantation. To effectively prepare the marrow microenvironment for HSC transplantation it is important to understand which of the molecular pathways regulating the function of the microenvironment are disrupted under the specific pathological condition. In this study we have shown that endogenous HA, the level of which could be decreased by irradiation, chemotherapy, hormone therapy, aging, and other conditions, is an important component of the bone marrow hematopoietic microenvironment. Disruption of HA production by pharmacological inhibition of HAS activity decreased hematopoietic activity in vitro and reduced the ability of the bone marrow microenvironment to recruit HSCs to the marrow in vivo.
4MU has been reported to be a potent inhibitor of HA synthesis (23), and we confirmed this by showing that levels of HA were decreased in 4MU-treated LTBMC. Interestingly, we found that protein levels of HAS2 and HAS3 were decreased in LTBMC adherent layers, whereas the level of HAS1 was not changed. These effects of 4MU correlated well with the dramatic decrease in production of hematopoietic cells in LTBMC. In line with these findings, lack of hematopoiesis in LTBMC from tHAS1/2/3 KO bone marrow was observed, whereas hematopoietic activity in dHAS1/3 KO cultures was comparable with that from control WT cultures. Together, these findings suggest that HA associated with the stromal microenvironment is required for hematopoiesis.
The lack of hematopoietic activity in the 4MU-treated LTBMC could be mediated by several distinct mechanisms. However, it is not due to the toxic effect of 4MU on bone marrow cells. By using annexin V binding and trypan blue exclusion tests we have shown that at 300 M 4MU does not induce apoptosis and cell death, whereas higher concentrations are toxic. Furthermore, the addition of 300 M 4MU in methylcellulose cultures did not change the number and size of colonies, suggesting that at this concentration 4MU does not interfere with colony formation. Because the cobblestone areas and hematopoietic foci within the adherent layer of 4MU-treated LTBMC are not formed, it is likely that the pool of multipotent HSCs and committed progenitors is affected indirectly, through interfering with the hematopoiesis supportive function of the hematopoietic microenvironment.
Consistent with the effect of 4MU on hematopoiesis, HA-depleted cultures treated with exogenous HA showed a corresponding increase in the number of progenitors as measured by the CFU assay. These stimulatory effects of HA in 4MU-treated cultures are mediated, at least in part, by CD44, which is in line with our previously published findings (16, 28 -30) . However, the role of other glycosaminoglycans, such as CS, and other receptors (TLR4 (40, 41) , RHAMM (42) , and HARE (43)) cannot be excluded and requires additional investigation.
The analyses of CM from LTBMC demonstrated a striking increase in the concentrations of a variety of proliferation-stimulating cytokines in the HMW HA-stimulated cultures. Notable concentration changes occurred in factors that stimulate proliferation of HSCs and progenitors directly, such as IGFBP-3 (44) and LIX/CXCL5 (45), as well as those that act synergistically with other cytokines to induce proliferation, such as IL-12 (46) . In addition to positive regulators, HMW HA stimulated production of some negative regulators of HSPC proliferation such as IL-8, which has been shown to be a negative regulator of myeloid progenitor cell proliferation (47, 48) . However, the suppressive effects of IL-8 can be blocked by MIP-2␤ (47), which was also up-regulated by HMW HA in our cultures. We have also detected increased concentrations of MIP-1␣ and MIP-1␤ in HMW HA-CM, of which MIP-1␣ was reported to inhibit proliferation and colony formation of myeloid progenitor cells (47) . However, Broxmeyer and colleagues (47) have also shown that MIP-1␤ can block the suppressive effects of MIP-1␣ on progenitor cell proliferation. We also detected that HMW HA stimulates the production of MCP-1 in LTBMC. The effects of MCP-1 on HSPC proliferation are controversial: several groups have reported that MCP-1 inhibits progenitor cell proliferation (49, 50), whereas others have described its hematopoiesis-promoting activity (51). Interestingly, HMW HA stimulated the production of soluble VCAM-1 in LTBMC. Soluble VCAM-1 inhibits the VLA-4/ VCAM-1 cell adhesion pathway and might contribute to the detachment of progenitor cells from the niche (52) . When detached, the progenitor cells become more sensitive to stimulatory factors (53) , and this might contribute to the overall stimulatory effects of HA on hematopoiesis in LTBMC. HMW HA is known to have a stimulatory effect on cell surface expression and turnover of VCAM-1 (18) , which may explain the increased sVCAM-1 concentrations observed in LTBMC. Collectively, the results of the cytokine analyses demonstrate the complexity of the effects of HA on hematopoiesis. Positive and negative factors form a network that regulates proliferation of stem cells and committed progenitors according to physiological demands. HA appears to be one of the key molecules that control the balance between positive and negative regulators of HSC proliferation.
Given that HA regulates the production of cytokines and chemokines involved in cell trafficking, it was important to determine whether HA affected the motility of cells in LTBMC. Indeed, analysis of the time lapse microscopy recordings demonstrated that cells in HA-treated LTBMC moved faster, and correspondingly, their velocity was decreased when HA is degraded. HA has been previously reported to influence cell motility of fibroblasts (15) , and soluble HA is reported to inhibit transmigration of human HSPC (54) . Therefore, we investigated whether the motility effects observed in HA-treated LTBMC were mediated by HA or by the HA-induced chemokines. We found that HA did not directly influence SDF-1-mediated chemotaxis of hematopoietic cells, but HA-CM acted synergistically with SDF-1 to increase chemotaxis. Protein microarray analysis demonstrated that HA regulates production of several chemokines, including MCP-1, RANTES, and MIPs, which alone have no or low effect of migration of hematopoietic progenitors, whereas in the presence of SDF-1 were shown to exhibit a synergistic effect (55) . Thus, as a component of the local microenvironment, HA regulates the production of chemokines that may contribute to the recruitment of circulating HSCs and progenitors into the bone marrow, as illustrated in Fig. 8 . However, the effect of HA in marrow is not limited to regulation of soluble factor production. HA is also known to contribute to soluble factor sequestration, retention, and presentation, mediating cell crawling, and interactions with the vasculature (56 -58) .
Until now the lack of appropriate mouse models has made it challenging to study the role of endogenous HA in vivo. Although all three HA synthases, HAS1, HAS2, and HAS3, are present in bone marrow, HAS2 appears to be the dominant HA synthase producing HMW HA. HAS1 and HAS3 knock-out mice are both viable (59, 60) because HAS2 can compensate the production of HA; by contrast, HAS2 knock-out mice demonstrate embryonic lethality (33) . This prompted us to develop an alternate approach to inhibit HAS2 in marrow. Previous studies have demonstrated that in addition to hematopoietic ablation, whole body irradiation sharply decreases the concentration of glycosaminoglycans, including HA, in mouse spleen and bone marrow (61) . During exposure to irradiation, HA undergoes chemical degradation and depolymerization (62) . Irradiation induces HA chain fragmentation, and dose-dependently affects the three-dimensional polymeric structure of HA (63, 64) . Thus, irradiation induces a synchronous disruption and degradation of HA, but does not interfere with HA synthesis (65) (66) (67) . Importantly, 4MU exerts inhibitory effects on HA synthesis by effectively depleting cellular UDP-GlcA, one of the two substrates needed for HA synthesis (23) and causes a profound disruption of HA synthesis in vitro (68) . Previous studies have shown that injection of mice with 4MU profoundly inhibits HA synthesis for at least 3 h post-injection (69) . Thus, for our in vivo model we used a combination of irradiation and 4MU treatment to induce a transient but marked decrease in marrow HA concentrations.
The homing and CRA experiments demonstrated that recruitment of transplanted HSCs into the marrow is less efficient in mice that were treated with 4MU in addition to lethal irradiation. The recruitment of circulating HSCs into marrow (i.e. homing) is a multistep process, which involves rolling of HSCs on the luminal surface of endothelial cells (low affinity adhesive interactions), subsequent firm adhesion (high affinity adhesive interactions), followed by transmigration through the endothelial cell layer. Because HA is expressed on the surface of bone marrow-derived endothelial cells, it is possible that the reduced homing efficiency in 4MU-treated animals is in part due to the lack of HA on the endothelial cell surface. We tested this hypothesis by growing nontreated and 4MU-treated bone marrow-derived endothelial cells in microcapillary tubes, and testing their ability to support rolling and adhesion of FDCPmix cells under conditions of physiological shear stress. Consistent with our hypothesis, we found that endothelial cells with reduced surface expression of HA are significantly less able to support adhesive interactions with hematopoietic cells under conditions of physiological shear stress. Thus, tHAS1/2/3 KO mice, in which HAS2 is conditionally deleted in cells of mesenchymal origin only might be a better experimental model to address the role of microenvironment-associated HA in regulating functions of stem cells.
Interestingly, lack of HA production by cells of mesenchymal origin correlates with re-distribution of progenitors in tHAS1/ 2/3 KO mice as compared with dHAS1/3 KO and WT mice. We found a decreased number of progenitors in bone marrow and increased number of progenitors in blood, spleen, and liver of tHAS1/2/3 KO mice, whereas in dHAS1/3 KO mice the number of progenitors in tissues was similar to that in WT mice. Interestingly, increased levels of marrow-associated HA in hyaluronidase 2 KO mice also resulted in hematopoietic abnormalities (70) . Thus, a complex machinery that involves HA synthesis, binding, retention, accumulation, degradation, and clearance should be orchestrated to maintain optimal levels of HA in healthy tissues. Together, our findings and observations published by others suggest that the tissue-associated HA in bone marrow might be clinically relevant and reflect the biological health of the hematopoietic microenvironment.
Collectively, our results strongly suggest that HA is a biologically active component of the hematopoietic microenvironment and is involved in regulating hematopoietic homeostasis. Because some treatments or compounds reduce HA concentrations in tissues (32) and some conditions are associated with increased levels of HA (71), it may prove clinically useful to monitor the dynamics of endogenous HA recovery to aid in identifying the optimal time for stem cell transplantation. Our data also suggest that biologically active exogenous HA polymers of the correct size, source, and conformation as well as HA synthesis inhibitors may have potential use in clinical hematology to correct misbalanced HA levels.
